Sentinel lymph node biopsy before or after neoadjuvant chemotherapy: pros and cons

Area of Science:

• Oncology
• Surgical Oncology
• Breast Cancer Research

Background:

• Neoadjuvant chemotherapy is increasingly used for breast cancer.
• Sentinel lymph node (SLN) biopsy is a standard staging procedure.
• The optimal timing of SLN biopsy relative to neoadjuvant chemotherapy is debated.

Purpose of the Study:

• To summarize the advantages and disadvantages of performing SLN biopsy before versus after neoadjuvant chemotherapy.
• To address clinical questions regarding the accuracy and prognostic information from each approach.

Main Methods:

• Review of prospective trials and institutional policies on SLN biopsy timing.
• Analysis of data comparing SLN biopsy accuracy after neoadjuvant chemotherapy versus before.
• Evaluation of prognostic information obtained from each timing strategy.

Main Results:

• Performing SLN biopsy before neoadjuvant chemotherapy avoids concerns about post-chemotherapy accuracy.
• Pre-chemotherapy SLN biopsy can provide information influencing adjuvant therapy decisions.
• Trials have investigated the safety and accuracy of post-chemotherapy SLN biopsy.

Conclusions:

• The timing of SLN biopsy in patients receiving neoadjuvant chemotherapy has significant implications.
• Performing SLN biopsy before neoadjuvant chemotherapy is a strategy to ensure accuracy and guide treatment.
• Further research is ongoing to establish definitive guidelines for post-neoadjuvant chemotherapy SLN biopsy.